References: Kimura N, Ohmori K, Miyazaki K, Izawa M, Matsuzaki Y, Yasuda Y, Takematsu H, Kozutsumi Y, Moriyama A, Kannagi R. Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2. J Biol Chem. 2007 Nov 2;282(44):32200-7. (GL7, FA, human cells, PubMed)
Naito Y, Takematsu H, Koyama S, Miyake S, Yamamoto H, Fujinawa R, Sugai M, Okuno Y, Tsujimoto G, Yamaji T, Hashimoto Y, Itohara S, Kawasaki T, Suzuki A, Kozutsumi Y. Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation. Mol Cell Biol. 2007 Apr;27(8):3008-22.
Han, S., B. Zheng, Y. Takahashi, and G. Kelsoe. Distinctive characteristics of germinal center B cells. Semin. Immunol. 1997; 9: 255 - 260.
Han, S., S.R. Dillon, B. Zheng, M. Shimoda, M.S. Schlissel, and G. Kelsoe. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 1997; 278: 301 - 305.
Han, S., B. Zheng, D.G. Schatz, E. Spanopoulou, and G. Kelsoe. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science 1996; 274: 2094 - 2097.
Hathcock, K.S., C.E.M. Pucillo, G. Laszlo, L. Lai, and R.J. Hodes. Analysis of thymic subpopulations expressing the activation antigen GL7. Expression, genetics, and function. J. Immunol. 1995; 155: 4575 - 4581.
Laszlo, G., K.S. Hathcock, H.B. Dickler, and R.J. Hodes. Characterization of a novel cell-surface molecule expressed on subpopulations of activated T and B cells. J. Immunol. 1993; 150: 5252 - 5262.